Published in Br J Urol on February 01, 1991
The growing teratoma syndrome: Current review of the literature. Indian J Urol (2009) 1.32
Growing teratoma syndrome of ovary. Int J Clin Oncol (2008) 1.13
Growing teratoma syndrome and peritoneal gliomatosis. Case Rep Med (2011) 0.96
Interferon-α Treatment for Growing Teratoma Syndrome of the Testis. Case Rep Nephrol Urol (2013) 0.76
Growing Teratoma Syndrome. Indian J Surg Oncol (2016) 0.75
Growing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature. Urol Case Rep (2013) 0.75
Re: The growing teratoma syndrome. G. M. Jeffery et al. Br. J. Urol., 67, 195-202, 1991. Br J Urol (1992) 0.75
Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study. Case Rep Oncol (2015) 0.75
Uses of barium meal examination in dyspeptic patients under 50. Br Med J (1977) 3.82
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology (1996) 2.74
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol (2000) 2.55
Is adult-onset coeliac disease due to a low-grade lymphoma of intraepithelial T lymphocytes? Lancet (1991) 2.21
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst (1999) 2.15
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol (2006) 1.97
Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology (1987) 1.78
Calcium oxalate crystals (Weddellite) within the secretions of ductal carcinoma in situ--a rare phenomenon. J Clin Pathol (1999) 1.76
Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol (1994) 1.72
Mucinous metaplasia of the penis. Histopathology (2002) 1.65
Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol (1993) 1.64
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
'Lambing ears': a blistering disorder affecting farmers at lambing time. Br J Dermatol (2007) 1.59
Orange-red birefringence of gold particles in paraffin wax embedded sections: an aid to the diagnosis of chrysiasis. Histopathology (1994) 1.56
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer (1997) 1.55
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J Clin Pathol (2001) 1.49
Pagetoid spread into the rete testis by testicular tumours. Histopathology (1994) 1.47
The continued value of central histopathological review of testicular tumours. Histopathology (2005) 1.46
Bilateral testicular germ cell tumours: an increasing incidence and prevention by chemotherapy. Br J Urol (1988) 1.42
An unusual solitary circumscribed neuroma (palisaded encapsulated neuroma) of the skin--with observations on the nature of pseudo-epitheliomatous hyperplasia. Histopathology (1991) 1.41
Developing new drugs for cancer. BMJ (1991) 1.39
An audit of the clinical diagnosis of sebaceous cyst. Br J Dermatol (1993) 1.39
Zero-inflated Poisson regression with random effects to evaluate an occupational injury prevention programme. Stat Med (2001) 1.38
The value of central histopathological review of testicular tumours before treatment. BJU Int (1999) 1.35
Nuclear restoration of cytoplasmic male sterility in sunflower is associated with the tissue-specific regulation of a novel mitochondrial gene. EMBO J (1994) 1.34
Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun (2002) 1.32
Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology (2000) 1.30
Antitubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody (SMA). Clin Exp Immunol (1980) 1.30
One and two view mammography in breast cancer. Are carcinomas detected by one and two view mammography similar? BMJ (1996) 1.30
Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol (2008) 1.27
Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology (1989) 1.24
Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol (2001) 1.23
Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol (1991) 1.22
Epileptic seizures associated with cisplatin administration. Cancer Treat Rep (1982) 1.22
Giant cell myocarditis: evidence for the macrophage origin of the giant cells. J Clin Pathol (1985) 1.19
Malignant melanoma re-excision specimens--how many blocks? Histopathology (1998) 1.18
IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun (2001) 1.16
Chylothorax in lymphoma: mechanisms and management. Ann Oncol (1995) 1.16
Diet and ovarian cancer risk: a case-control study in China. Br J Cancer (2002) 1.12
Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology (2001) 1.11
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer (1997) 1.09
Health-related behaviours as predictors of mortality and morbidity in Australian Aborigines. Prev Med (2006) 1.09
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Br J Cancer (2000) 1.08
Microinvasive carcinoma of the breast: diagnostic criteria and clinical relevance. Histopathology (1999) 1.08
Confocal microscopy of idarubicin localisation in sensitive and multidrug-resistant bladder cancer cell lines. Br J Cancer (1996) 1.06
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer (1999) 1.06
Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. J Virol (1993) 1.05
Localized amyloidosis of the lower genitourinary tract: a clinicopathological and immunohistochemical study of nine cases. Histopathology (1992) 1.05
Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens. Dig Dis Sci (1989) 1.05
Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol (1986) 1.04
Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res (2001) 1.04
Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet (2003) 1.04
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol (1998) 1.04
The painful prostate. Br J Urol (1975) 1.03
Unusual cystic change in classic seminoma of the testis. Am J Surg Pathol (2006) 1.03
Lack of a serologic response to an E1B protein of adenovirus 12 in coeliac disease. Scand J Gastroenterol (1989) 1.03
Autosomal dominant polycystic kidney disease complicated by glomerulonephritis. Nephron (1992) 1.02
Involvement of the gastrointestinal tract by metastases from germ cell tumors of the testis. Cancer (1988) 1.02
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer (1998) 1.02
Modern management of non-Hodgkin's lymphoma. Br Med J (Clin Res Ed) (1986) 1.01
ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors. Ann Oncol (2006) 1.00
Bleomycin-related lung damage: CT evidence. Radiology (1985) 1.00
Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol (1998) 1.00
The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol (R Coll Radiol) (1997) 0.99
Primary pure teratoma of the testis. J Urol (1996) 0.99
Aluminium and injection site reactions. J Clin Pathol (1996) 0.97
The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy. Br J Urol (1974) 0.97
Immunohistological detection of Legionella pneumophila in lung sections. J Clin Pathol (1987) 0.97
Painful sclerosis of the medial end of the clavicle. Clin Radiol (2004) 0.96
T cell and mononuclear phagocyte populations of the human small and large intestine. Adv Exp Med Biol (1987) 0.96
Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer. BJU Int (2002) 0.96
Treatment of head-and-neck cancer. Lancet (1982) 0.96
A phase II study of tamoxifen in ovarian cancer. Eur J Cancer Clin Oncol (1986) 0.96
Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet (2002) 0.94
A quantitative food frequency questionnaire for women in southeast China: development and reproducibility. Asia Pac J Public Health (2005) 0.94
Bleeding oesophageal varices and hepatic dysfunction in adult polycystic kidney disease. Br Med J (Clin Res Ed) (1984) 0.94
Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer (1999) 0.94
Sclerosing lymphocytic lobulitis of the breast. Clin Radiol (1995) 0.93
Staging and prognostic factors in testicular cancer. Semin Surg Oncol (1999) 0.93
Drug-associated primary acute pancreatitis. Lancet (1978) 0.92
Measuring resident satisfaction in residential aged care. Gerontologist (2001) 0.92
Non-Hodgkin's lymphoma arising in skeletal muscle. Ann Oncol (1991) 0.92
Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method. Histopathology (1996) 0.91
Combined goblet cell carcinoid and mucinous cystadenoma of the appendix. J Clin Pathol (1995) 0.90
ChlVPP chemotherapy in advanced Hodgkin's disease. Eur J Cancer Clin Oncol (1989) 0.90